Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
about
Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairmentApolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein.The proteome of sickle cell disease: insights from exploratory proteomic profiling.ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis.Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits.Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritisImplications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemiaAPO A2 -265T/C Polymorphism Is Associated with Increased Inflammatory Responses in Patients with Type 2 Diabetes Mellitus.Determinants of variation in human serum paraoxonase activityImpact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetesHigh density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular diseaseThe relationship between high density lipoprotein subclass profile and apolipoprotein concentrations.High-density lipoprotein and atherosclerosis: the role of antioxidant activity.Role of apolipoprotein A-II in the structure and remodeling of human high-density lipoprotein (HDL): protein conformational ensemble on HDL.Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases.HDL particle subpopulations: Focus on biological function.Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism.Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport.Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitorsThe interaction between ApoA2 -265T>C polymorphism and dietary fatty acids intake on oxidative stress in patients with type 2 diabetes mellitus.Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit.Beneficial effects of omega-3 fatty acids in the proteome of high-density lipoprotein proteome.Surface rheology and adsorption kinetics reveal the relative amphiphilicity, interfacial activity, and stability of human exchangeable apolipoproteins.Consumption of polyunsaturated fat improves the saturated fatty acid-mediated impairment of HDL antioxidant potential.Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency.HDL subfraction distribution of paraoxonase-1 and its relevance to enzyme activity and resistance to oxidative stress.A Caucasian male with very low blood cholesterol and low apoA-II without evidence of atherosclerosis.Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics.Unravelling HDL-Looking beyond the Cholesterol Surface to the Quality Within
P2860
Q33878870-85E75761-3E5C-4AB7-BE25-6A54088ECAD0Q34314185-9FF94B57-7894-458E-B9F5-068C6F71EBDEQ34746400-B96A74D1-D13B-4960-9014-FF1D79F9777DQ35098335-DC473F81-2183-442F-856C-DB39081F415DQ36903963-3E74291B-B69B-43CA-AA11-8F8A63027E57Q36955395-17A40364-AD42-4CA7-8A57-9FB473EE6DD6Q37015961-5ABEB364-CB08-47D0-A10D-8973A5B1F535Q37056843-47BDDDDF-8AAB-450E-AFF9-ED0D3FBC34F9Q37098232-E2116124-F20F-4CB8-9C18-7C51FC83D6B3Q37112920-7A109214-680A-4A7E-9196-8E2A547B3760Q37305341-900B222B-B541-44B0-8043-76946D2FF030Q37900093-EC7BC3CA-FC9E-4155-A50C-9D7825FCAFAFQ37996363-BE74FB37-DC12-4B12-87ED-E0C53CB5E401Q38013180-302EEE27-7101-4C34-97D9-1F4EC8104616Q38062539-25CC066B-A37E-4C48-94AB-DD68E76787CEQ38391229-EF64EA0E-4189-4769-8AA6-255847F3C969Q38839105-83869C15-EB69-4C44-BE3D-CDA7D67033D8Q39141274-4F65D4CC-098E-47A8-B5C6-59929E8CE352Q39910687-899FD226-3DB3-4B77-833B-19144DE27951Q40714647-B0BF1A79-EE7A-4AD3-A328-9D5B7830662DQ41115717-D7C069A6-0DAF-4F99-B14B-2D4EAD37F02DQ42232637-405F7B45-A4B5-49A0-A22C-06FB3659B06AQ43043912-EFA6C95B-3952-468E-851F-21DD689DC028Q46708533-1C4DAD7C-F587-47A8-BD14-A32B4E2340B9Q51082527-593D1729-E74D-467B-947F-1DA5334598FBQ51790864-D3492F13-BD31-4B4A-8ED5-FABC577F59A0Q53575103-6519A191-002A-4225-A820-F82C6A3AF035Q55333947-BD8D131E-1CCE-4D15-A951-06C904608B48Q57176950-715003FD-E29E-4D88-9A17-A426D2D7559B
P2860
Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Human apolipoprotein A-II enri ...... and antiatherogenic potential.
@en
Human apolipoprotein A-II enri ...... and antiatherogenic potential.
@nl
type
label
Human apolipoprotein A-II enri ...... and antiatherogenic potential.
@en
Human apolipoprotein A-II enri ...... and antiatherogenic potential.
@nl
prefLabel
Human apolipoprotein A-II enri ...... and antiatherogenic potential.
@en
Human apolipoprotein A-II enri ...... and antiatherogenic potential.
@nl
P50
P1433
P1476
Human apolipoprotein A-II enri ...... and antiatherogenic potential
@en
P2093
P304
P356
10.1161/01.RES.0000146031.94850.5F
P50
P577
2004-09-23T00:00:00Z